Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 128, Issue 1, Pages 36-44Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI93556
Keywords
-
Categories
Funding
- NIH [HL093096, HL121267]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093096, R01HL121267] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Genetic investigations of fibrotic diseases, including those of late onset, often yield unanticipated insights into disease pathogenesis. This Review focuses on pathways underlying lung fibrosis that are generalizable to other organs. Herein, we discuss genetic variants subdivided into those that shorten telomeres, activate the DNA damage response, change resident protein expression or function, or affect organelle activity. Genetic studies provide a window into the downstream cascade of maladaptive responses and pathways that lead to tissue fibrosis. In addition, these studies reveal interactions between genetic variants, environmental factors, and age that influence the phenotypic spectrum of disease. The discovery of forces counterbalancing inherited risk alleles identifies potential therapeutic targets, thus providing hope for future prevention or reversal of fibrosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available